Report cover image

Neuroendocrine Tumor Treatment Global Market Report 2025

Publisher The Business Research Company
Published Feb 28, 2025
Length 200 Pages
SKU # BRC19655109

Description

Neuroendocrine Tumor Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroendocrine tumor treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for neuroendocrine tumor treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroendocrine tumor treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Somatostatin Analogs (SSAs); Targeted Therapy; Chemotherapy; Others Products

2) By Indication: Lungs; Pancreas; Gastrointestinal; Others Indications

3) By End-Users: Hospitals; Oncology Centers; Other End-Users

Subsegments:

1) By Somatostatin Analogs (SSAs): Octreotide; Lanreotide

2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Peptide Receptor Radionuclide Therapy (PRRT)

3) By Chemotherapy: Traditional Chemotherapy Agents; Combination Chemotherapy Regimens

4) By Other Products: Immunotherapy; Supportive Care Medications

Companies Mentioned: Pfizer Inc.; F Hoffmann-La Roche AG; Abbvie Inc.; Novartis AG; Sanofi SA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

200 Pages
1. Executive Summary
2. Neuroendocrine Tumor Treatment Market Characteristics
3. Neuroendocrine Tumor Treatment Market Trends And Strategies
4. Neuroendocrine Tumor Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Neuroendocrine Tumor Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Neuroendocrine Tumor Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neuroendocrine Tumor Treatment Market Growth Rate Analysis
5.4. Global Neuroendocrine Tumor Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neuroendocrine Tumor Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neuroendocrine Tumor Treatment Total Addressable Market (TAM)
6. Neuroendocrine Tumor Treatment Market Segmentation
6.1. Global Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Somatostatin Analogs (SSAs)
Targeted Therapy
Chemotherapy
Others Products
6.2. Global Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lungs
Pancreas
Gastrointestinal
Others Indications
6.3. Global Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Oncology Centers
Other End-Users
6.4. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Somatostatin Analogs (SSAs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Octreotide
Lanreotide
6.5. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tyrosine Kinase Inhibitors (TKIs)
Peptide Receptor Radionuclide Therapy (PRRT)
6.6. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Traditional Chemotherapy Agents
Combination Chemotherapy Regimens
6.7. Global Neuroendocrine Tumor Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunotherapy
Supportive Care Medications
7. Neuroendocrine Tumor Treatment Market Regional And Country Analysis
7.1. Global Neuroendocrine Tumor Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neuroendocrine Tumor Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neuroendocrine Tumor Treatment Market
8.1. Asia-Pacific Neuroendocrine Tumor Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neuroendocrine Tumor Treatment Market
9.1. China Neuroendocrine Tumor Treatment Market Overview
9.2. China Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neuroendocrine Tumor Treatment Market
10.1. India Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neuroendocrine Tumor Treatment Market
11.1. Japan Neuroendocrine Tumor Treatment Market Overview
11.2. Japan Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neuroendocrine Tumor Treatment Market
12.1. Australia Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neuroendocrine Tumor Treatment Market
13.1. Indonesia Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neuroendocrine Tumor Treatment Market
14.1. South Korea Neuroendocrine Tumor Treatment Market Overview
14.2. South Korea Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neuroendocrine Tumor Treatment Market
15.1. Western Europe Neuroendocrine Tumor Treatment Market Overview
15.2. Western Europe Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neuroendocrine Tumor Treatment Market
16.1. UK Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neuroendocrine Tumor Treatment Market
17.1. Germany Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neuroendocrine Tumor Treatment Market
18.1. France Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neuroendocrine Tumor Treatment Market
19.1. Italy Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neuroendocrine Tumor Treatment Market
20.1. Spain Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neuroendocrine Tumor Treatment Market
21.1. Eastern Europe Neuroendocrine Tumor Treatment Market Overview
21.2. Eastern Europe Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neuroendocrine Tumor Treatment Market
22.1. Russia Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neuroendocrine Tumor Treatment Market
23.1. North America Neuroendocrine Tumor Treatment Market Overview
23.2. North America Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neuroendocrine Tumor Treatment Market
24.1. USA Neuroendocrine Tumor Treatment Market Overview
24.2. USA Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neuroendocrine Tumor Treatment Market
25.1. Canada Neuroendocrine Tumor Treatment Market Overview
25.2. Canada Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neuroendocrine Tumor Treatment Market
26.1. South America Neuroendocrine Tumor Treatment Market Overview
26.2. South America Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neuroendocrine Tumor Treatment Market
27.1. Brazil Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neuroendocrine Tumor Treatment Market
28.1. Middle East Neuroendocrine Tumor Treatment Market Overview
28.2. Middle East Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neuroendocrine Tumor Treatment Market
29.1. Africa Neuroendocrine Tumor Treatment Market Overview
29.2. Africa Neuroendocrine Tumor Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neuroendocrine Tumor Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neuroendocrine Tumor Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neuroendocrine Tumor Treatment Market Competitive Landscape And Company Profiles
30.1. Neuroendocrine Tumor Treatment Market Competitive Landscape
30.2. Neuroendocrine Tumor Treatment Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Neuroendocrine Tumor Treatment Market Other Major And Innovative Companies
31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca
31.3. Takeda Pharmaceutical
31.4. Eli Lilly And Company
31.5. Amgen Inc.
31.6. Merck & Co. Inc.
31.7. Boehringer Ingelheim International GmbH
31.8. Servier
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Ipsen Pharma SAS
31.11. Exelixis Inc.
31.12. Advanced Accelerator Applications SA
31.13. Hutchison Medipharma Ltd.
31.14. Tarveda Therapeutics
31.15. GlycoMira Therapeutics Inc.
32. Global Neuroendocrine Tumor Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neuroendocrine Tumor Treatment Market
34. Recent Developments In The Neuroendocrine Tumor Treatment Market
35. Neuroendocrine Tumor Treatment Market High Potential Countries, Segments and Strategies
35.1 Neuroendocrine Tumor Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Neuroendocrine Tumor Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Neuroendocrine Tumor Treatment Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us